These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 27069189)
21. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Jung K; Lein M; Stephan C; Von Hösslin K; Semjonow A; Sinha P; Loening SA; Schnorr D Int J Cancer; 2004 Sep; 111(5):783-91. PubMed ID: 15252851 [TBL] [Abstract][Full Text] [Related]
22. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer. Capeller B; Caffier H; Sütterlin MW; Dietl J Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340 [TBL] [Abstract][Full Text] [Related]
24. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton. Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373 [TBL] [Abstract][Full Text] [Related]
25. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis. Chao TY; Wu YY; Janckila AJ Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857 [TBL] [Abstract][Full Text] [Related]
26. [Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease]. Strippoli S; Stucci S; Dammacco F; Silvestris F Recenti Prog Med; 2011 Feb; 102(2):88-95. PubMed ID: 21513124 [TBL] [Abstract][Full Text] [Related]
27. Survival markers related to bone metastases in prostate cancer. Salminen EK; Kallioinen MJ; Ala-Houhala MA; Vihinen PP; Tiitinen SL; Varpula M; Vahlberg TJ Anticancer Res; 2006; 26(6C):4879-84. PubMed ID: 17214355 [TBL] [Abstract][Full Text] [Related]
28. Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases. Selander KS; Brown DA; Sequeiros GB; Hunter M; Desmond R; Parpala T; Risteli J; Breit SN; Jukkola-Vuorinen A Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):532-7. PubMed ID: 17372249 [TBL] [Abstract][Full Text] [Related]
29. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer. Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166 [TBL] [Abstract][Full Text] [Related]
30. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Halleen JM Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342 [TBL] [Abstract][Full Text] [Related]
31. Plasma acid and alkaline phosphatase in patients with breast cancer. Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338 [TBL] [Abstract][Full Text] [Related]
32. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases. Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852 [TBL] [Abstract][Full Text] [Related]
33. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients. Chao TY; Yu JC; Ku CH; Chen MM; Lee SH; Janckila AJ; Yam LT Clin Cancer Res; 2005 Jan; 11(2 Pt 1):544-50. PubMed ID: 15701839 [TBL] [Abstract][Full Text] [Related]
34. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290 [TBL] [Abstract][Full Text] [Related]
35. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis. Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479 [TBL] [Abstract][Full Text] [Related]